AzTrials
AzTrials

Skin AgingPhase 4NCT00352157

Effect of Revival Soy on Weight Loss and Skin, Hair, and Nails in Premenopausal Women

A Phase 4 study testing Revival Soy Dietary Supplement in people with Skin Aging and Weight Loss, run by Physicians Pharmaceuticals, Inc. at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if dietary consumption of Revival Soy can improve the appearance of the skin, hair, and finger nails and support weight loss in overweight, premenopausal women. Read more about this study

Who is it for?
Ages 25 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Skin Aging, Weight Loss
What is being tested?
Revival Soy Dietary Supplement
How many people
40 participants
Where
1 siteUnited States
Study dates
Jul 2006to Mar 2007
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Females
  • Age: 25-45 years.
  • BMI between 30 - 40 kg/m2.
  • Motivated to lose weight.
  • Subjects must be in general good health as determined from a medical history.
  • Subjects must have mild to moderate photoaging.
Show all 10Show fewer
  • Subjects must use a shampoo from the approved list without change for the entire duration of the study.
  • Must not be consuming soy supplements or other soy products currently.
  • Must not be pregnant (negative pregnancy test at screening) and agree not to become pregnant during the course of the study.
  • Subjects must read and sign the informed consent form after the nature of the study has been fully explained.

Who cannot join

  • Subjects with known allergies or sensitivities to ingredients contained in the dietary supplement.
  • Subjects who are required to spend excessive time in the sun (i.e. lifeguards, other outdoor workers).
  • Subjects who are currently participating or have participated within the last 4 weeks in any other clinical study (i.e., dermal patch, use tests, investigational drug or devices, etc.).
  • Subjects viewed by the investigator as not being able to complete the study.
  • Subjects who are unwilling to leave all of their current skin care products unchanged for the 6 months of the study.
  • Subjects who are unwilling to leave all of their current nail care products unchanged for the 6 months of the study.
Show all 10Show fewer
  • Subjects who are unwilling to leave all of their current oral medications unchanged for the 6 months of the study.
  • Subjects who have experienced large variations in body weight during the previous 3 months
  • Subjects currently using other weight loss medications or supplements.
  • Subjects who had surgical intervention for the treatment of obesity.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Dermatology Consulting Services

    High Point, North Carolina, 27262

Other trials in United States

About this study

Official title: Effect of Revival Soy on Weight Loss and Appearance of Skin, Hair, and Nails in High BMI Premenopausal Women

The purpose of this study is to determine if dietary consumption of Revival Soy can improve the appearance of the skin, hair, and finger nails and support weight loss in overweight, premenopausal women.

Read the detailed description

The researchers hypothesize that supplementation of Revival® Soy products to overweight premenopausal women as part of a soy-based meal replacement diet plan will:

  • Improve the health and appearance of the skin by normalizing skin pigmentation and reducing wrinkles,
  • Improve the health and appearance of hair by enhancing sheen and ease of combing, and
  • Improve the health and appearance of nails by enhancing shine, flexibility, and strength.
  • Stimulate a loss in weight and a reduction in the Body Mass Index (BMI),

For this study, obese (BMI = 30-40 kg/m2) premenopausal women (25-45 years of age) with mild to moderate photoaging (n=40) will receive either a Revival® soy shake (20 grams soy protein with 160 mg total isoflavones; n=20) or a placebo shake (20 grams of milk protein with 0 mg isoflavones; n=20) daily for 6 months. The subjects will be asked to come into the office for a total of seven visits, at baseline and at monthly intervals for 6 months. At baseline, month 3, and month 6, the subjects will be asked to complete a questionnaire in order to provide self-reported improvements related to hair, skin, and nail health. Following completion of the questionnaire, the investigator and the dermatology clinic staff will examine the subjects to assess the health and appearance of their skin, hair, and nails at baseline, month 3, and month 6.

After acceptance into the study, a registered dietitian will instruct the study subjects in the use of a low-energy (1,200 - 1,500 kcal/day) diet that incorporates 2 soy-based daily meal replacements (shakes, ~500 kcal), a minimum of 5 daily servings of fruits and vegetables (~300 kcal), and one entrée (~400 - 500 kcal). Subjects will be required to keep a dietary food intake record of all food and supplement use during the trial. Anthropometric data (height, body weight, waist circumference and hip circumference) will be collected at baseline and at monthly intervals.

Being tested
Revival Soy Dietary Supplement
Keywords
Soy, Dermatology, Skin, Hair, Finger Nails, Weight Loss, Body Mass Index, Photoaging of Skin, Skin Wrinkling
Medical subject headings
Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Revival Soy Dietary SupplementBehavioural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Investigator assessed appearance of skin (roughness, wrinkling, dyspigmentation, and redness) at baseline and after 3 and 6 months

  2. Investigator assessed appearance of hair (roughness, dullness, lack of manageability, and scalp flaking) at baseline and after 3 and 6 months

  3. Investigator assessed appearance of finger nails (roughness, ridging, flaking, and splitting) at baseline and after 3 and 6 months.

Secondary outcomes (3)
  1. Body weight at monthly intervals

  2. Body mass index (BMI) at the baseline and study completion

  3. Subject-perceived changes in appearance of skin, hair, and finger nails at baseline and after 3 and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2006 (estimated)
  2. Study startJul 2006
  3. Study completionMar 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Enrolment
40 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00352157
Sponsor's protocol ID
DCS-61-06
Status last verified
Jul 2009
First submitted
13 Jul 2006
Last updated
21 Jul 2009
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Revival Soy Dietary Supplement in people with Skin Aging and Weight Loss, run by Physicians Pharmaceuticals, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jul 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Investigator assessed appearance of skin (roughness, wrinkling, dyspigmentation, and redness) at baseline and after 3 and 6 months. The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in